BDBM434288 US10562891, Example 210::US10562891, Example 211a::US10562891, Example 211b::US11008308, Example 211b

SMILES F[C@H]1CNCC[C@@H]1SCc1nc2cc(NC3CCCC3)cc(F)c2c(=O)[nH]1

InChI Key

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 434288   

TargetProtein mono-ADP-ribosyltransferase PARP14 [1611-1801](Homo sapiens (Human))
Ribon Therapeutics

US Patent
LigandPNGBDBM434288(US10562891, Example 210 | US10562891, Example 211a...)
Affinity DataIC50: <1.00E+3nMAssay Description:Enzymatic inhibition of PARP14 was measured using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) monitoring the auto-modificati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein mono-ADP-ribosyltransferase PARP14 [1611-1801](Homo sapiens (Human))
Ribon Therapeutics

US Patent
LigandPNGBDBM434288(US10562891, Example 210 | US10562891, Example 211a...)
Affinity DataIC50: <1.00E+3nMAssay Description:Enzymatic inhibition of PARP14 was measured using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) monitoring the auto-modificati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein mono-ADP-ribosyltransferase PARP14(Homo sapiens (Human))
Ribon Therapeutics

US Patent
LigandPNGBDBM434288(US10562891, Example 210 | US10562891, Example 211a...)
Affinity DataIC50: <1.00E+3nMAssay Description:Enzymatic inhibition of PARP14 was measured using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) monitoring the auto-modificati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein mono-ADP-ribosyltransferase PARP14(Homo sapiens (Human))
Ribon Therapeutics

US Patent
LigandPNGBDBM434288(US10562891, Example 210 | US10562891, Example 211a...)
Affinity DataIC50: <1.00E+3nMAssay Description:Enzymatic inhibition of PARP14 was measured using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) monitoring the auto-modificati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein mono-ADP-ribosyltransferase PARP14(Homo sapiens (Human))
Ribon Therapeutics

US Patent
LigandPNGBDBM434288(US10562891, Example 210 | US10562891, Example 211a...)
Affinity DataIC50: <1.00E+3nMAssay Description:Enzymatic inhibition of PARP14 was measured using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) monitoring the auto-modificati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein mono-ADP-ribosyltransferase PARP14 [1611-1801](Homo sapiens (Human))
Ribon Therapeutics

US Patent
LigandPNGBDBM434288(US10562891, Example 210 | US10562891, Example 211a...)
Affinity DataIC50: <1.00E+3nMAssay Description:Enzymatic inhibition of PARP14 was measured using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) monitoring the auto-modificati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent